Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Current assets:    
Cash and cash equivalents $ 100,766 $ 136,308
Restricted cash 2,571 10,215
Accounts receivable, net of allowance for credit losses of approximately $501 and $562 as of January 31, 2025 and January 31, 2024, respectively 178,989 185,638
Prepaid expenses and other current assets 50,527 53,170
Total current assets 332,853 385,331
Goodwill 317,071 317,071
Intangible assets, net 427,221 539,293
Operating right-of-use assets 4,936 8,044
Other assets 23,988 23,895
Total assets 1,106,069 1,273,634
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 44,980
Accounts payable 13,458 14,512
Accrued Employee Benefits, Current 47,803 31,774
Accrued expenses and other current liabilities 24,231 29,939
Operating lease liabilities 1,791 3,049
Deferred revenue 282,295 282,570
Total current liabilities 376,982 413,228
Long-term debt 573,267 577,487
Deferred tax liabilities 42,039 52,148
Operating long-term lease liabilities 6,431 9,251
Deferred revenue - non-current 1,656 2,402
Other long-term liabilities 11,848 13,531
Total long-term liabilities 635,241 654,819
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value: 18,750,000 shares authorized and 8,616,633 shares issued and 8,316,856 shares outstanding as of January 31, 2025, and 8,380,436 shares issued and 8,080,659 shares outstanding as of January 31, 2024 1 1
Additional paid-in capital 1,565,040 1,551,005
Accumulated deficit (1,443,386) (1,321,478)
Treasury stock, at cost- 299,777 as of January 31, 2025 and January 31, 2024 (10,891) (10,891)
Accumulated other comprehensive income (loss) (16,918) (13,050)
Total shareholders’ equity (deficit) 93,846 205,587
Total liabilities and shareholders’ equity (deficit) $ 1,106,069 $ 1,273,634